#1 Ranked Children’s Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
There are many ways you can help children and their families get the care they need.
Osteoblastoma is a benign, bone-forming tumor that is extremely rare, accounting for only 1 percent of all primary bone tumors. Unlike most primary bone tumors, which favor the extremities, osteoblastoma occurs most often in the lower vertebrae of the spine or long bones of the lower extremity. It can, however, also occur in any of the bones of the arms, legs, hands and feet. Most of the time, osteoblastoma is not aggressive, but it can produce painful symptoms. One form of this tumor is considered aggressive because it is very likely to recur after incomplete surgical removal. No reported osteoblastoma has transformed into a malignant condition. The aggressive form does not metastasize (spread) to other parts of the body.
We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”